Drawing for CELLDX

USPTO serial 99271923

CELLDX

Reviewed by CopyMark Law Group

Reg. 8236051Status 700Registered
Filing date
Status date
Registration date
Apr 28, 2026
Examiner
ZAVALA DIEK, JOSEPH MARCO
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELLDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher E. Gatewood

Christopher E. Gatewood Threshold Counsel, PC1905 Huguenot Rd Suite 200Richmond, VA 23235United States

Goods and services

ClassDescriptionStatusFirst use
044Medical diagnostic testing services, namely, providing in-depth molecular analysis of tumor cells and tumor-derived genetic material for the purposes of assessing tumor burden, detecting genetic alterations, guiding personalized treatment selection, monitoring therapeutic response, and detecting recurrence in cancer patientsACTIVESep 1, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 28, 2026NRCSNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 28, 2026R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Apr 1, 2026CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Feb 25, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 25, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 25, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 25, 2025DOCKASSIGNED TO EXAMINER—
Nov 12, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 8, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 8, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance